tert-Butyl (3-((1,3-dioxoisoindolin-2-yl)oxy)propyl)carbamate

Catalog No.: 
ACQTGU982
CAS No.: 
894414-29-0
Molecular Formula: 
C16H20N2O5
Molecular Weight: 
320.35
tert-Butyl (3-((1,3-dioxoisoindolin-2-yl)oxy)propyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$328.00InquiryInquiry
250mg98%$598.00InquiryInquiry
1g98%$1520.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (3-((1,3-dioxoisoindolin-2-yl)oxy)propyl)carbamate
IUPAC Nametert-butyl (3-((1,3-dioxoisoindolin-2-yl)oxy)propyl)carbamate
Molecular FormulaC16H20N2O5
Molecular Weight320.35
SMILESCC(C)(C)OC(=O)NCCCON1C(=O)C2=C(C=CC=C2)C1=O
InChI KeyFJHOAAXBCPGLOF-UHFFFAOYSA-N
Synonym(1,3-dioxoisoindolin-2-yl)-propan-NH-Boc;Carbamic acid, N-[3-[(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)oxy]propyl]-, 1,1-dimethylethyl ester
CAS No.894414-29-0

Synthetic Route by SureRoute

1. ACQTGU982 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXJGP473 route compound structure diagram
    ACXJGP47378888-18-3In Stock
  2. Plus
  3. ACWHOJ803 route compound structure diagram
    ACWHOJ803524-38-9In Stock
  4. Then
  5. ACQTGU982 route product structure diagram
    ACQTGU982894414-29-0
Inquiry

2. ACQTGU982 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACROUM564 route compound structure diagram
    ACROUM56458885-58-8In Stock
  2. Plus
  3. ACWHOJ803 route compound structure diagram
    ACWHOJ803524-38-9In Stock
  4. Then
  5. ACQTGU982 route product structure diagram
    ACQTGU982894414-29-0
Inquiry

3. ACQTGU982 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQTGU982 route product structure diagram
    ACQTGU982894414-29-0
Inquiry

Comments (0)